James P. Scanlan, Attorney at Law

Home Page

Curriculum Vitae

Publications

Published Articles

Conference Presentations

Working Papers

page1

Journal Comments

Truth in Justice Articles

Measurement Letters

Measuring Health Disp

Outline and Guide to MHD

Summary to MHD

Solutions

page3

Solutions Database

Irreducible Minimums

Pay for Performance

Between Group Variance

Concentration Index

Gini Coefficient

Reporting Heterogeneity

Cohort Considerations

Relative v Absolute Diff

Whitehall Studies

AHRQ's Vanderbilt Report

NHDR Measurement

NHDR Technical Issues

MHD A Articles

MHD B Conf Presentations

MHD D Journal Comments

Consensus/Non-Consensus

Spurious Contradictions

Institutional Corresp

page2

Scanlan's Rule

Outline and Guide to SR

Summary to SR

Bibliography

Semantic Issues

Employment Tests

Case Study

Case Study Answers

Case Study II

Subgroup Effects

Subgroup Effects NC

Illogical Premises

Illogical Premises II

Inevitable Interaction

Interactions by Age

Literacy Illustration

RERI

Feminization of Poverty S

Explanatory Theories

Mortality and Survival

Truncation Issues

Collected Illustrations

Income Illustrations

Framingham Illustrations

Life Table Illustrations

NHANES Illustrations

Mort/Surv Illustration

Credit Score Illustration

Intermediate Outcomes

Representational Disp

Statistical Signif SR

Comparing Averages

Meta-Analysis

Case Control Studies

Criminal Record Effects

Sears Case Illustration

Numeracy Illustration

Obesity Illusration

LIHTC Approval Disparitie

Recidivism Illustration

Consensus

Algorithm Fairness

Mortality and Survival 2

Mort/Survival Update

Measures of Association

Immunization Disparities

Race Health Initiative

Educational Disparities

Disparities by Subject

CUNY ISLG Eq Indicators

Harvard CRP NCLB Study

New York Proficiency Disp

Education Trust GC Study

Education Trust HA Study

AE Casey Profic Study

McKinsey Achiev Gap Study

California RICA

Nuclear Deterrence

Employment Discrimination

Job Segregation

Measuring Hiring Discr

Disparate Impact

Four-Fifths Rule

Less Discr Alt - Proc

Less Discr Altl - Subs

Fisher v. Transco Serv

Jones v. City of Boston

Bottom Line Issue

Lending Disparities

Inc & Cred Score Example

Disparities - High Income

Underadjustment Issues

Absolute Differences - L

Lathern v. NationsBank

US v. Countrywide

US v. Wells Fargo

Partial Picture Issues

Foreclosure Disparities

File Comparison Issues

FHA/VA Steering Study

CAP TARP Study

Disparities by Sector

Holder/Perez Letter

Federal Reserve Letter

Discipline Disparities

COPAA v. DeVos

Kerri K. V. California

Truancy Illustration

Disparate Treatment

Relative Absolute Diff

Offense Type Issues

Los Angeles SWPBS

Oakland Disparities

Richmond Disparities

Nashville Disparities

California Disparities

Denver Disparities

Colorado Disparities

Nor Carolina Disparitie

Aurora Disparities

Allegheny County Disp

Evansville Disparities

Maryland Disparities

St. Paul Disparities

Seattle Disparities

Minneapolis Disparities

Oregon Disparities

Beaverton Disparities

Montgomery County Disp

Henrico County Disparitie

Florida Disparities

Connecticut Disparities

Portland Disparities

Minnesota Disparities

Massachusetts Disparities

Rhode Island Disparities

South Bend Disparities

Utah Disparities

Loudoun Cty Disparities

Kern County Disparities

Milwaukee Disparities

Urbana Disparities

Illinois Disparities

Virginia Disparities

Behavior

Suburban Disparities

Preschool Disparities

Restraint Disparities

Disabilities - PL 108-446

Keep Kids in School Act

Gender Disparities

Ferguson Arrest Disp

NEPC Colorado Study

NEPC National Study

California Prison Pop

APA Zero Tolerance Study

Flawed Inferences - Disc

Oakland Agreement

DOE Equity Report

IDEA Data Center Guide

Duncan/Ali Letter

Crim Justice Disparities

U.S. Customs Search Disp

Deescalation Training

Career Criminal Study

Implicit Bias Training

Drawing Inferences

Diversion Programs

Minneapolis PD Investig

Offense Type Issues CJD

Innumerate Decree Monitor

Massachusetts CJ Disparit

Feminization of Poverty

Affirmative Action

Affirm Action for Women

Other Affirm Action

Justice John Paul Stevens

Statistical Reasoning

The Sears Case

Sears Case Documents

The AT&T Consent Decree

Cross v. ASPI

Vignettes

Times Higher Issues

Gender Diff in DADT Term

Adjustment Issues

Percentage Points

Odds Ratios

Statistical Signif Vig

Journalists & Statistics

Multiplication Definition

Prosecutorial Misconduct

Outline and Guide

Misconduct Summary

B1 Agent Cain Testimony

B1a Bev Wilsh Diversion

B2 Bk Entry re Cain Call

B3 John Mitchell Count

B3a Obscuring Msg Slips

B3b Missing Barksdale Int

B4 Park Towers

B5 Dean 1997 Motion

B6 Demery Testimony

B7 Sankin Receipts

B7a Sankin HBS App

B8 DOJ Complicity

B9 Doc Manager Complaints

B9a Fabricated Gov Exh 25

B11a DC Bar Complaint

Letters (Misconduct)

Links Page

Misconduct Profiles

Arlin M. Adams

Jo Ann Harris

Bruce C. Swartz

Swartz Addendum 2

Swartz Addendum 3

Swartz Addendum 4

Swartz Addendum 7

Robert E. O'Neill

O'Neill Addendum 7

Paula A. Sweeney

Robert J. Meyer

Lantos Hearings

Password Protected

OIC Doc Manager Material

DC Bar Materials

Temp Confidential

DV Issues

Indexes

Document Storage

Pre 1989

1989 - present

Presentations

Prosec Misc Docs

Prosec Misc Docs II

Profile PDFs

Misc Letters July 2008 on

Large Prosec Misc Docs

HUD Documents

Transcripts

Miscellaneous Documents

Unpublished Papers

Letters re MHD

Tables

MHD Comments

Figures

ASPI Documents

Web Page PDFs

Sears Documents

Pages Transfer


Mortality/Survival Illustration

(May 27, 2013)

 Prefatory note:  This subpage of the Scanlan’s Rule is closely related to the following other subpages that use particular types of data to illustrate the pattern whereby the rarer an outcome the greater tends to be the relative difference in experiencing it and the smaller tends to be the relative difference in avoiding it: Framingham Illustrations, NHANES Illustrations,  Life Tables Illustrations, Income Illustrations, Credit Score Illustrations.


The Mortality and Survival page discusses the fact that, particularly in studies concerning racial differences in cancer outcomes, researchers commonly refer to relative differences in survival and relative differences in mortality interchangeably, often stating they are analyzing one relative difference while in fact analyzing the other, but without recognizing that the two relative differences tend to change in opposite directions as overall survival rates change or that more survivable conditions tend to show larger relative differences in mortality but smaller relative differences in survival than less survivable conditions.  Several of the tables on that page illustrate the pattern whereby the rarer an outcome the greater tends to be the relative difference in experiencing it and the smaller tends to be the relative difference in avoiding it.  These include Table N1, which presents an example where localized cancer shows a smaller relative difference in survival but larger relative difference in mortality than regionalized cancer.  Table 1 below present similar data on five-years survival/mortality for nine types of cancer according to three stages (local, regional, distant) based on Figure 4 of the American Cancer Society’s Cancer Facts and Figures for African Americans 2013-2014.  The final column also shows the EES, for estimated effect size, which is a measure of disparity theoretically unaffected by the prevalence of an outcome (as discussed on the Solutions subpage of Measuring Health Disparities page). 

Table 1.  White and black five-year survival rates by type of cancer and stage with ratio of white survival rate to black survival rate and black mortality rate to white mortality rate and estimate effect size (from American Cancer Society data) [refb4127a2]


TypeStageWSRBSRWBSuvrRatioBWMortRatioEES
Female Breast Localized 99.00% 93.00% 1.06 7.00 0.86
Female Breast Regional 85.00% 73.00% 1.16 1.80 0.43
Female Breast Distant 25.00% 15.00% 1.67 1.13 0.37





Colorectum Localized 90.00% 86.00% 1.05 1.40 0.21
Colorectum Regional 70.00% 64.00% 1.09 1.20 0.18
Colorectum Distant 12.00% 9.00% 1.33 1.03 0.17





Esophagus Localized 40.00% 20.00% 2.00 1.33 0.59
Esophagus Regional 21.00% 14.00% 1.50 1.09 0.28
Esophagus Distant 3.00% 3.00% 1.00 1.00





Lung & Bronchus Localized 53.00% 44.00% 1.20 1.19 0.24
Lung & Bronchus Regional 25.00% 23.00% 1.09 1.03 0.07
Lung & Bronchus Distant 4.00% 4.00% 1.00 1.00





Oral Cav & Pharnyx Localized 83.00% 75.00% 1.11 1.47 0.29
Oral Cav & Pharnyx Regional 60.00% 38.00% 1.58 1.55 0.58
Oral Cav & Pharnyx Distant 35.00% 24.00% 1.46 1.17 0.33





Prostate Localized 100.00% 100.00% 1.00

Prostate Regional 100.00% 100.00% 1.00

Prostate Distant 28.00% 27.00% 1.04 1.01 0.03





Urinary Bladder Localized 70.00% 62.00% 1.13 1.27 0.23
Urinary Bladder Regional 33.00% 29.00% 1.14 1.06 0.13
Urinary Bladder Distant 6.00% 6.00% 1.00 1.00





Uterine Cervix Localized 92.00% 84.00% 1.10 2.00 0.42
Uterine Cervix Regional 58.00% 51.00% 1.14 1.17 0.19
Uterine Cervix Distant 17.00% 11.00% 1.55 1.07 0.28





Uterine Corpus Localized 96.00% 85.00% 1.13 3.75 0.72
Uterine Corpus Regional 70.00% 44.00% 1.59 1.87 0.7
Uterine Corpus Distant 18.00% 9.00% 2.00 1.11 0.43






There are only minor departures from the pattern whereby as survival decreases from stage to stage, relative differences in mortality decrease while relative differences in survival increase.

One observes a more striking pattern when the focus is limited to the stages with the highest and lowest survival and the common situation where the white survival rate is greater than the black survival rates for both stages, as shown in Table 2. 

Table 2.  White and black five-year survival rates by type of cancer and stage with ratio of white survival rate to black survival rate and black mortality rate to white mortality rate and estimated effect size (limited to local and distant and situations where white survival is greater than black survival for both stages) (from American Cancer Society data) [refb4127a4]



TypeStageWSRBSRWBSuvrRatioBWMortRatioEES
Female Breast Localized 99.00% 93.00% 1.06 7.00 0.86
Female Breast Distant 25.00% 15.00% 1.67 1.13 0.37





Colorectum Localized 90.00% 86.00% 1.05 1.40 0.21
Colorectum Distant 12.00% 9.00% 1.33 1.03 0.17





Oral Cav & Pharnyx Localized 83.00% 75.00% 1.11 1.47 0.29
Oral Cav & Pharnyx Distant 35.00% 24.00% 1.46 1.17 0.33





Uterine Cervix Localized 92.00% 84.00% 1.10 2.00 0.42
Uterine Cervix Distant 17.00% 11.00% 1.55 1.07 0.28





Uterine Corpus Localized 96.00% 85.00% 1.13 3.75 0.72
Uterine Corpus Distant 18.00% 9.00% 2.00 1.11 0.43